Skip to main content
main-content

Diabetic hypoglycemia: Recognizing the under-recognized

COMING SOON


​​​​​​​

A blended education program designed by Springer Healthcare IME, in collaboration with the International Hypoglycaemia Study Group (IHSG), for all diabetes specialists, primary care physicians and specialist diabetes nurses working in the treatment and management of patients with diabetes.

Despite advances in treatment, hypoglycemia remains a prevalent complication of diabetes which is often overlooked. Newer insulins and technologies have the potential to reduce the risk of hypoglycemia and its complications. To achieve these benefits, they must be correctly integrated into an individualized treatment regimen, taking patient fears and choice into account. 

This program aims to support clinicians in a time of rapidly changing treatment choices, providing practical guidance in identifying and managing diabetic hypoglycemia.

Would you like to know more?

Sign up here

Program director

Simon Heller

Professor Simon Heller, UK Read his biography

Program at-a-glance

Interactive map

Interactive map to show the real-world global burden of hypoglycemia
Statistics, trends, and comments from experts around the world to address local hypoglycemia prevalence with links to the latest published real-world data.

Interactive glucose profiles

Interactive glucose profile graphs with expert video interviews to cover the appropriate introduction and use of different insulins and technology
User-controlled treatment decisions based on different patient profiles and needs, with expert commentary on different treatment paths and consequences.
Faculty: Professor Timothy Jones (Australia), Dr. Emma Wilmot (UK)

Patient case studies

Expert-led interactive patient case studies to address different hypoglycemia presentations, complications and treatment options
Faculty: Professor Kamlesh Khunti (UK), Dr. Yingying Luo (China), Professor Ulrik Pedersen-Bjergaard (Denmark)

Practical workshop

Practical workshop with hypothetical patient–doctor consultations, discussing patient fears and how to manage them
Insights into how new technologies can facilitate self-monitoring and management to reduce patient fears and risk of hypoglycemia. 
Faculty: Professor Stephanie Amiel (UK) with comments from Professor Simon Heller and Dr. Emma Wilmot​​​​​​​

Learning objectives

Upon completion of the educational activities in this series, learners will be able to:

  • Describe the latest real-world data on the prevalence of hypoglycemia and its impact on patients worldwide
  • Appraise novel insulin therapies and technologies, including how to integrate them into clinical practice to improve glucose and reduce the risk of hypoglycemia and its complications
  • Debate the psychological consequences of hypoglycemia on the patient and the self-management strategies that may negate these

Educational grant

This program has been made possible with an educational grant from Novo Nordisk A/S.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Imedex and Springer Healthcare IME. Imedex is accredited by the ACCME to provide continuing medical education for physicians.

Contact us

Email: IME@springer.com
Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK

SH IME_IHSG


image credits